THE STERILIZATION OF LIPOVACCINES by Lewis, Paula A. & Dodge, Francis W.
THE  STERILIZATION OF LIPOVACCINES. 
BY PAUL A.  LEWIS, M.D.,  AND FRANCIS W.  DODGE. 
(From the U. S. Naval Laboratory, the Henry Phipps Institute  of the University of 
Pennsylvania, Philadelphia.) 
(Received for publication, November 14, 1919.) 
The proposal  to  substitute  suspensions of bacterial  bodies  in  off 
for suspensions in saline solution as  a  vaccine for use in combating 
typhoid fever and pneumonia theoretically offers great  advantages. 
Provided the vaccination is  safe and efficient, it would be  of great 
importance to be able  to get the same result with a  single applica- 
tion that has, in the past, been accomplished with three doses of the 
prophylactic. 
The evidence so far at hand would seem to show that the vaccina- 
tion  with  oily  suspensions  causes  a  formation  of  antibodies 
comparable with  that  afforded by  suspensions in  water,  and  thus 
renders  it  probable  that  a  similar  degree  of  protection  may  be 
given  by  the  lipovaccine.  The  matter  is,  however,  of  sufficient 
importance to justify repeated examination. 
When material of this nature is to be widely distributed its sterility 
should be assured both by the method of  preparation  and  control 
tests on the fin~shed product.  In this respect the methods proposed 
by  Whitmore  and  FenneF  are  not  altogether  satisfactory.  The 
procedures recommended afford many opportunities for  contamina- 
tion, the oil interferes with  the  action of  antiseptics  so  that  these 
cannot be depended upon for a  final sterilization, and lastly it is far 
from  easy  to  make  satisfactory  tests  for  sterility  on  the  finished 
product. 
Rosenow  and  Osterberg,*  recognizing  these  difficulties,  propose 
to kill the bacteria  and any contaminating organisms with a  w~ter 
solution of an antiseptic, to form an emulsion with the oil, and finally 
l Whitmore, E. R., and Fennel, E. A., Y. Am. Med. Assn., 1918, lxx, 902. 
2 Rosenow, E. C., and Osterberg, A. E., Y. Am. Med. Assn., 1919, lxxiii, 87. 
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to remove the water by vacuum distillation at a  comparatively low 
temperature.  This  appears  from their statement  to be  an  efficient 
method of preparation. 
In approaching this matter we have followed another line of thought 
and wish to record our results at this time as a  contribution to the 
subject without, however, attempting to decide which method may 
in the end be best. 
Loeflter  ~ has stated that by the  application of  dry  heat  bacteria 
may be  killed  without  destroying their  antigenic properties.  The 
temperature he used was 70°C.  and the exposure was prolonged for 
days  or  weeks.  It  is  known  that  glassware  and  fabrics  may  be 
sterilized by exposure to dry heat for a  number of hours, the length 
of  exposure varying inversely with  the  temperature.  Thus  130°C. 
for 3 hours is as efficient as 160°C.  for 1 hour.  The suspensions of 
bacteria in oil are essentially dry preparations, and it seemed possible 
that the finished vaccine could be sterilized at an intermediate tem- 
perature without destroying its antigenic qualities.  As a  matter of 
fact, our results indicate that this may be accomplished with pneu- 
mococcus.  We have so far been unsuccessful with Bacillus typhosus. 
EXPERI~NTAL. 
Pneumococcus lipovaccine was prepared according to  the method 
of  Whitmore  and  Fennel.  1  Briefly,  the  bacteria  were  grown  in 
glucose  broth  and  separated  by  centrifugalization  after  about  18 
hours  growth.  The  bacterial  mass  was  dried in  an  oven  at  53°C. 
over lime.  The dry mass was ground in a Pyrex jar with steel balls 
for a number of hours, a mixture of anhydrous lanolin and cottonseed 
off  (Wesson)  added,  and  the  grinding  continued.  Finally,  sterile 
cottonseed off containing 0.25  per cent chloretone was added in such 
amount  that  each  cubic  centimeter of  the  finished product  would 
contain  2  rag.  of  the  dried  bacterial  powder.  The  grinding  was 
then continued for a number of hours, the product put  into  suitable 
bottles or ampules and sealed as ready for distribution. 
Control tests for sterility revealed the presence of Bacillus subtilis 
and  sometimes  other  bacteria  in  the  dried  mass  in  a  majority  of 
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instances.  When  the  dried  bacterial  mass  was  dean  the  finished 
product  was  nearly  always sterile.  The pneumococcus does  not 
survive the drying process.  If  the  dried mass  containing Bacillus 
s~btiUs  is  ground in  oil  containing  chloretone  this  contaminating 
organism will remain viable for months.  With experience in manipu- 
lation  the  amount of material  lost  because  of  contamination was 
reduced, but even with  the greatest care it  always remained high. 
In an attempt to overcome this dlf6culty we exposed the finished 
vaccine to a  temperature of 130°C.  for 3  hours in an electric oven 
(Freas),  and to  120°C.  for  12  hours,  temperatures which are  suffi- 
ciently  high  to  sterilize  any  material.  The  vaccine,  heated  and 
unheated, was administered to healthy mice (0.5 cc. subcutaneously), 
and after varying periods the resistance of the mice to pneumococcus 
infection was tested by intraperitoneal injection of doses of culture 
known to be fatal, or multiples thereof.  The results of two experi- 
ments are given in Tables I  and II. 
The  experiments show  that  a  considerable  degree  of  protection 
is  afforded  to  mice  by  the  administration  of  pneumococcus lipo- 
vaccine.  In the occasional instances in which the vaccinated mice 
died it was found that the vaccine had not been absorbed,  almost 
the  whole  mass  injected  remaln~ng  in  the  subcutaneous  tissues. 
Protection is exerted against at least ten fatal doses of culture.  The 
mice in the experiments reported had been treated with vaccine 35 
and 38 days previously.  In other experiments in which the interval 
was 21, 55, and 110 days, there was no evidence of protection, indi- 
cating that  the immunity following a  single dose of lipovacdue is 
slow to develop and is transient.  The heat treatment did not decrease 
the antigenic qualities of the vaccine appreciably. 
The administration of vaccine in practice as a prophylactic against 
pneumonia is still in the stage of trial.  Since at present the qualities 
of typhoid vaccine are of much greater interest, we have extended 
our work to include this phase of the subject. 
Typhoid  lipovacdne  4 similarly heated and unheated  was  admin- 
istered to rabbits intraperitoneally, a single dose of 1 cc. being given. 
The blood was  tested for its  agglutinin content at intervals there- 
4 The vaccines used in this  experiment were  obtained  from  the U.  S. Army 
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TABLE I. 
Protection Test of Mice Treated witlf Pneumococcus Lipovaccine. 
The vaccinating  dose was administered  35  days before the  test.  The  test 
consisted of inoculation with the indicated quantity of a 24 hour bouillon culture 
injected intraperitoneally  with  normal  salt  solution  sufficient  to make  a  total 
volume of 0.5 ce. 
Vaccine. 
None  .....................  f 
Unheated .................  I 
Heated to  130°C.  for  3  hrs.., t 
Heated to 1200C. for 12 hrs.. 
l'ypc 
III 
Ill 
HI 
III 
I 
I 
I 
I 
HI 
I51 
III 
III 
I 
I 
I 
I 
HI 
III 
III 
HI 
I 
I 
I 
I 
HI 
III 
HI 
III 
I 
I 
I 
I 
Culture. 
Dilution. 
1:10,000,000 
1:10,000,000 
1:100,000,000 
1:100,000,000 
1  :I0,000,000 
1:10,000,000 
1:100,000,000 
1:100,000,000 
1:10,000,000 
1:10,000,000 
1:100,000,000 
1  :I00,000,000 
1:10,000,000 
1:10,000,000 
1:100,000,000 
1:100,000,000 
1:10,000,000 
1:10,000,000 
1:100,000,000 
1:100,000,000 
1:10,000,000 
1:10,000,000 
1:100,000,000 
1:100,000,000 
1  :I0,000,000 
1:10,000,000 
1:100,000,000 
1:100,000,000 
1:10,000,000 
1:10,000,000 
1:100,000,000 
1:100,000,000 
Result. 
After 48 
hrs. 
Sick. 
Dead. 
Sick. 
Dead. 
Sick. 
g~ 
Sick. 
Sick. 
Sick. 
¢¢  cg 
¢¢  g¢ 
¢#  ¢¢ 
#g  ¢¢ 
"  Dead. 
"  Sick. 
After 72 l  hrs__.~. 
Dead. I 
Dead. I 
Dead. 
After 96 
hrs. 
Well. 
Well. 
Well. 
Well. 
Well. 
¢¢ 
c¢ 
c¢ 
Well PAUL  A.  LEWIS  AND  FRANCIS  W.  DODGE  173 
TABLE  II. 
ProWaion Test of Mice Treated with Pneumococcus Lipovaccine. 
The vaccinating dose was given 38 days before the test.  The test consisted 
of inoculation with the indicated quantity of a 24 hour bouillon culture of Type I 
pneumococcus intraperitoneally.  The total volume injected was 0.5 cc. 
Vaccine. 
None ..................................... 
Unheated  ................................. 
Heated to 130°C. for 3 hrs  ................... 
Dilution of culture. 
1:1,000,000 
1:1,000,000 
1:1,000,000 
1 :  1,000,000 
1:1,000,000 
1:1,000,000 
1:1,000,000 
1:1,000,000 
1:1,000,000 
1:1,000,000 
1:1,000,000 
1:1,000,000 
1:1,000,000 
1:1,000,000 
1:1,000,000 
1:1,000,000 
1:1,000,000 
I  1:1,000,000 
1:1,000,000 
1:1,000,000 
l  1:1,000,000 
1 :  1,000,000 
1:1,000,000 
Result. 
After 24  After 48 hrs. 
Si,  c,k  Dead.,, 
Dea 
Sick  Dead., 
Dea~ 
Sick.  Dead. 
Dea~ 
Well  Well. 
Sick  " 
"  Dead. 
"  Well. 
,c  ,, 
,,  ,4 
,¢  ,, 
,,  ,g 
"  Dead. 
after.  As a  control the results were compared with those obtained 
by  the  administration  of  three  doses  of  typhoid  vaccine  in  saline 
suspension  intraperitoneaily  at  5  day  intervals.  The  results  are 
presented in Table III. 
The experiment shows that  at least for these particular prepara- 
tions the lipovaccine is less efficient in single doses than is the saline 
preparation  in  three  doses.  The  antigenic  qualities  of  the  lipo- 
vaccine  (typhoid)  are  almost  destroyed by  heating  to  130°C.  for 
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SUMMARY. 
Pneumococcus  lipovaccine  confers  a  definite protection  against 
pneulnococcus  infection  in  mice.  The  protective  quality  is  not 
destroyed,  and  apparently  is  not  greatly  diminished, by  heating 
to 130°C. for 3 hours or 120°C. for 12 hours. 
Typhoid  lipovaccine gives  rise  to  the  formation  of  agglufinins 
in rabbits but to a lesser degree tlmn saline suspensions.  The anti- 
genic qualities of the typhoid lipovaccine are greatly injured by heat- 
ing to 130°C. for 3 hours. 